Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole PD176252 analogues as potential GRPR inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520622666220501162813
Abstract: BACKGROUND GRPR is over-expressed in cancer cells and is a potential drug target for the treatment of cancer. PD176252, as the most representative non-peptide inhibitor of GRPR, can inhibit the growth of cancer cells, but… read more here.
Keywords: grpr; cancer; affinity; pd176252 ... See more keywords